RecruitingNot ApplicableNCT06739759

Ovarian Hyperstimulation Syndrome Prevention

Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women


Sponsor

Aljazeera Hospital

Enrollment

300 participants

Start Date

Nov 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Ovarian hyperstimulation is a very hazardous complication of ICSI


Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 42 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at ways to prevent ovarian hyperstimulation syndrome (OHSS) in women with polycystic ovary syndrome (PCOS) who are undergoing fertility treatment (ICSI — a type of IVF). OHSS is a potentially serious complication where the ovaries overreact to fertility medications, causing bloating, pain, and in severe cases, fluid buildup. **You may be eligible if...** - You have been diagnosed with polycystic ovary syndrome (PCOS) - You are undergoing an ICSI (intracytoplasmic sperm injection) fertility procedure **You may NOT be eligible if...** - You do not have PCOS - You are not undergoing ICSI fertility treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAntagonist protocol for IVF

antagonist protocol with triggering by Decapeptyl

DRUGModified Agonist protocol for IVF with additive treatments as HCQ

giving additive drugs to agonist protocolas HCQ


Locations(2)

Aljazeerah hospital

Giza, Egypt

Algazeerah

Giza, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06739759